Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 
Online Report Subscribers, Click Here

Pricing and Ordering Information
ClearState

China Disease Incidence & Prevalence Report
Report #CS302CH -
April 2013


China Disease Incidence and Prevalence: Chronic diseases are proving to be a large burden to the healthcare system with a large proportion of the population suffering from cardiovascular diseases

With a population of 1.34 billion, China's rapid economic growth and changing demographics has driven the growth of the healthcare sector. In particular, lifestyle changes and an ageing population have led to a rapid rise in chronic diseases, especially cancer, hypertension and diabetes. Better living conditions and sedentary lifestyles are driving the increasing incidence of preventable chronic diseases even among younger people. It is estimated that one in five adults suffers from cardiovascular diseases, demonstrated by the significant contribution of cardiovascular procedures to the total volume of surgeries performed in China. There are more than 250 million people with hypertension in the country and almost 300 million people with dyslipidemia.

Fatty liver is also one of the most prevalent diseases in China, with an estimated 202 million people afflicted with the disease due to increasing obesity. Cancer incidence has increased significantly to 3.6 million, with lung, colorectal, stomach and liver cancer contributing significantly to total incidence rates. In addition, China's population is rapidly becoming older with the proportion of population aged 65 years and above expected to increase from 13% in 2012 to 34% by 2050. As a result, there is an increase in the prevalence of age-related diseases and in particular osteoporosis and urinary incontinence.

In addition China still has a high level of infectious diseases, with a total of more than three million cases in 2011. This is due to the disparity in healthcare provision and infrastructure between urban and rural areas. With on-going healthcare reform, basic coverage has been achieved for 96% of the population, and access to healthcare facilities and services has been improved. The incidence of many infectious diseases has decreased as a result; however, much progress is still be made to reduce the prevalence of infectious diseases.

Ordering Information

Title

Report# Publication
Date
List Price

China Disease Incidence & Prevalence Report

CS302CH

April 2013

$5,950

Order Online:
Single User only (Please call for corporate subscription pricing)
    PDF Only

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

METHODOLOGY STATEMENT

INTRODUCTION

 

1. CHINA HEALTHCARE OVERVIEW

1.1 Macroeconomic Overview

1.2 Social and Demographic Factors

1.3 Healthcare Reform

1.4 Hospital Services

1.5 Medical Devices

 

Exhibit 1-1:      Key Economic and Health Statistics

Exhibit 1-2:      Breakdown of Population by Province in China

Exhibit 1-3:      Top 10 Causes of Death in China

 

2. BLOOD DISORDERS

2.1 Anaemia

2.2 Haemophilia

 

Exhibit 2-1:      China, Prevalence of Blood Disorders

 

3. CANCER

3.1 Bladder Cancer

3.2 Brain Tumour

3.3 Breast Cancer

3.4 Cervical/Uterine Cancer

3.5 Colon/Rectal Cancer

3.6 Leukaemia

3.7 Liver Cancer

3.8 Lung Cancer

3.9 Lymphoma

3.10 Melanoma

3.11 Oesophageal Cancer

3.12 Oral Cancer

3.13 Ovarian Cancer

3.14 Pancreatic Cancer

3.15 Prostate Cancer

3.16 Stomach Cancer

 

Exhibit 3-1:      China, Incidence of Cancer

 

4. CARDIOVASCULAR DISORDERS

4.1 Cardiac Arrhythmia

4.2 Dyslipidemia

4.3 Heart Failure

4.4 Heart Valve Disorders

4.5 Hypertension

4.6 Vascular Disorders

 

Exhibit 4-1:      China, Prevalence of Cardiovascular Disorders

 

5. METABOLIC DISORDERS

5.1 Cholelithiasis and Cholecystitis

5.2 Chronic Kidney Disease / End-Stage Renal Disease

5.3 Diabetes

5.4 Fatty Liver

5.5 Urolithiasis

5.6 Peptic Ulcer

 

Exhibit 5-1:      China, Prevalence of Metabolic Disorders

 

6. MUSKULOSKELETAL DISORDERS

6.1 Arthritis

6.2 Carpal Tunnel Syndrome

6.3 Intervertebral Disc Disorder

6.4 Osteoporosis

 

Exhibit 6-1:      China, Prevalence of Musculoskeletal Disorders

 

7. NEUROLOGIC AND PSYCHIATRIC DISORDERS

7.1 Alzheimer’s Disease

7.2 Bipolar Disorder

7.3 Cerebrovascular Disease

7.4 Depression

7.5 Epilepsy

7.6 Hydrocephalus

7.7 Multiple Sclerosis

7.8 Myasthenia Gravis

7.9 Parkinson’s Disease

7.10 Schizophrenia

 

Exhibit 7-1:      China, Prevalence of Neurologic and Psychiatric Disorders

 

8. OPHTHALMIC DISORDERS

8.1 Cataracts

8.2 Glaucoma

 

Exhibit 8-1:      China, Prevalence of Ophthalmic Disorders

 

9. REPORODUCTIVE AND GENITOURINARY DISORDERS

9.1 Benign Prostatic Hyperplasia

9.2 Endometriosis

9.3 Erectile Dysfunction

9.4 Infertility

9.5 Urinary Incontinence

 

Exhibit 9-1:      China, Prevalence of Reproductive and Genitourinary Disorders

 

10. RESPIRATORY DISORDERS

10.1 Asthma

10.2 Bronchiectasis

10.3 Chronic Obstructive Pulmonary Disease

10.4 Pulmonary Embolism

 

Exhibit 10-1:    China, Prevalence of Respiratory Disorders

 

11. WOUNDS

11.1 Diabetic Ulcer

11.2 Pressure Ulcers

11.3 Surgical Wounds

11.4 Traumatic Wounds

 

Exhibit 11-1:    China, Prevalence of Wounds

 

12. SELECTED CONDITIONS CAUSED BY INFECTIOUS ORGANISMS

12.1 Brucellosis

12.2 Dysentery

12.3 Gonorrhoea

12.4 Human Immunodeficiency Virus / Acquired Immune Deficiency Syndrome

12.5 Measles

12.6 Syphilis

12.7 Tuberculosis

12.8 Viral Hepatitis

 

Exhibit 12-1:    China, Incidence of Conditions Caused by Infectious Organisms

 

APPENDIX: REFERENCES

Clearstate is a market intelligence firm offering customized strategic advisory and primary research solutions specifically addressing the Healthcare and Life Sciences domains within the Asia Pacific region. www.clearstate.com

To order reports or obtain information about special pre-publication offers from within the U.S., contact custcare@informa.com. You can also call 1.908.748.1221 (or toll-free within the U.S. at 1.800.332.2181) or fax 1.908.748.1222.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home